MoonLake Immunotherapeutics AG

03.04.2025

MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing (startupticker.ch)

09.01.2025

Positive developments at Swiss biotech companies (startupticker.ch)

27.05.2024

Biotechs record clinical trial successes (startupticker.ch)

01.05.2024

Triumphs and a setback in the biotech sector (startupticker.ch)

14.07.2023

Following encouraging Phase 2 results, MoonLake raises USD 400 million (startupticker.ch)

08.04.2022

MoonLake Immunotherapeutics goes public via SPAC (startupticker.ch)

06.04.2022

MoonLake Immunotherapeutics and Stalicla gear up for Phase 2 clinical studies (startupticker.ch)

14.10.2021

Zug-based biotech braces for IPO via SPAC (startupticker.ch)

12.08.2021

New executives take their seat (startupticker.ch)

11.05.2021

A newly launched biotech start-up with impressive study results in The Lancet (startupticker.ch)